Hercules Capital, Inc. (HTGC) - Q3 2021 Filing Summary
Business Context and Reporting Period
This summary covers the quarterly report (Form 10-Q) for Hercules Capital, Inc., a Business Development Company (BDC) and Small Business Investment Company (SBIC), for the period ended September 30, 2021. The Company provides senior secured loans to high-growth, venture capital-backed companies in technology, life sciences, and sustainable/renewable technology sectors.
Key Financial Metrics
| Metric | Q3 2021 (Three Months) | YTD 2021 (Nine Months) | YTD 2020 (Nine Months) |
|---|---|---|---|
| Total Investment Income | $70.2 million | $208.5 million | $211.9 million |
| Net Investment Income | $38.1 million | $109.6 million | $115.0 million |
| Net Realized Gain (Loss) | $21.1 million | $14.6 million | ($41.4 million) |
| Net Change in Unrealized Appreciation | ($35.7 million) | $46.2 million | $2.5 million |
| Net Increase in Net Assets from Operations | $23.5 million | $170.4 million | $76.1 million |
| Net Asset Value (NAV) per Share | $11.54 | $11.54 | $10.26 |
| Total Assets | $2.79 billion | $2.79 billion | $2.62 billion |
| Total Debt (Carrying Value) | $1.41 billion | $1.41 billion | $1.29 billion |
| Cash and Cash Equivalents | $235.9 million | $235.9 million | $198.3 million |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased to $2.51 billion from $2.35 billion at year-end 2020, driven by new fundings of approximately $1.07 billion (net of assignments to Adviser Funds) and early payoffs of $678.3 million.
- Debt Refinancing: The Company issued $325.0 million in September 2026 Notes and $50.0 million in March 2026 B Notes. It also fully redeemed the April 2025 Notes ($75.0 million) and significantly reduced balances on its 2027 and 2028 Asset-Backed Notes.
- Realized Gains: The Company recognized net realized gains of $14.6 million for the nine months ended September 30, 2021, a significant improvement from the $41.4 million net realized loss in the same period in 2020. Gains were primarily from sales of DoorDash, Palantir, and TransMedics, offset by write-offs of Intent Media and Solar Spectrum Holdings.
- Unrealized Depreciation: Q3 2021 saw a net unrealized depreciation of $35.7 million, primarily due to valuation adjustments in equity and warrant portfolios, contrasting with the net unrealized appreciation of $46.2 million for the full nine-month period.
- SBIC Activity: The Company wound down its HT III SBIC license in June 2021 and paid down all related SBA debentures. It simultaneously drew $64.5 million in SBA debentures through its new HC IV SBIC.
Guidance, Outlook, and Risks
- Outlook: Management maintains a variable distribution policy targeting 90-100% of taxable income. The Company expects to continue generating current income from debt investments and capital appreciation from equity/warrants.
- Liquidity: As of September 30, 2021, available liquidity was approximately $818.4 million, including $235.9 million in cash and significant unused capacity under credit facilities ($472 million) and SBA debentures ($110.5 million).
- Unfunded Commitments: The Company had $309.9 million in unfunded contractual commitments available at the request of portfolio companies.
- Risks:
- Concentration Risk: Seven portfolio companies represented greater than 5% of net assets, with BridgeBio Pharma LLC (8.6%) and Zepz (7.7%) being the largest.
- Interest Rate Risk: Approximately 95.9% of the debt portfolio bears floating interest rates. Rising rates are expected to increase interest income, though they may also increase borrowing costs on floating-rate debt.
- Valuation Risk: Approximately 90% of assets are Level 3 investments valued in good faith by the Board, subject to significant judgment and potential volatility.
- Subsequent Events: On October 20, 2021, the Company fully redeemed the remaining $289.2 million principal of its 2027 and 2028 Asset-Backed Notes using proceeds from the September 2026 Notes issuance.
Investor Verification Checklist
- Verify the impact of the $2.7 million loss on debt extinguishment recognized in October 2021 for the redemption of Asset-Backed Notes.
- Monitor the performance of the top seven portfolio companies, which collectively represent over 47% of net assets.
- Review the utilization of the $309.9 million in unfunded commitments and the timing of future fundings.
- Assess the sustainability of the dividend payout ratio given the mix of cash and non-cash (PIK) income.
- Track the drawdown and performance of the new HC IV SBIC facility compared to the wound-down HT III facility.